Pluto Bioinformatics

GSE141571: Dual Antimicrobial and Anti-inflammatory Activity of a Nitric Oxide-releasing Topical Medication in Atopic Dermatitis

Bulk RNA sequencing

A clinical trial assessed the cutaneous immune response and short-term efficacy, safety, and tolerability in adults with mild to moderate AD who applied SB414 2% and 6% BID for 2 weeks. SOURCE: Emma Guttman-Yassky (emma.guttman@mountsinai.org) - Emma Guttman Icahn School of Medicine at Mount Sinai